Medicare Enrolled

Dr. Flor Geola, M.D.

Endocrinology · Los Angeles, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
11600 WILSHIRE BLVD., Los Angeles, CA 90025
3104770501
In practice since 2006 (19 years)
NPI: 1851485049 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Geola from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Geola? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Geola

Dr. Flor Geola is an endocrinology specialist in Los Angeles, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Geola performed 2,074 Medicare services across 921 unique beneficiaries.

Between the years covered by Open Payments, Dr. Geola received a total of $2,891 from 26 pharmaceutical and/or device companies across 123 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Geola is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 29% volume in CA $2,891 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,074
Medicare services
Top 29% in CA for endocrinology
921
Unique beneficiaries
$91
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~109 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
777 $106 $200
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
581 $143 $275
Blood glucose test using hand-held instrument
A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels.
350 $3 $20
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
164 $76 $149
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
59 $8 $20
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
43 $12 $55
Home health plan of care certification
Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians.
40 $45 $115
New patient office visit, complex (60-74 min) 39 $182 $350
Prolonged office E/M service, first 15 minutes
This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service.
21 $26 $45
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,891
Total received (2018-2024)
Avg $413/year across 7 years
Top 37% in CA for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
26
Companies
123
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,891 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$502
2023
$635
2022
$436
2021
$371
2020
$75
2019
$281
2018
$592

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
SANOFI-AVENTIS U.S. LLC
$104
Abbott Laboratories
$80
Lilly USA, LLC
$74
Novo Nordisk Inc
$68
Amgen Inc.
$49
Mannkind Corporation
$48
Radius Health, Inc.
$29
Ascendis Pharma Inc
$29
ABBVIE INC.
$20
Top 3 companies account for 51.4% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$552
Novo Nordisk Inc
$515
Amgen Inc.
$359
SANOFI-AVENTIS U.S. LLC
$288
Merck Sharp & Dohme Corporation
$153
Abbott Laboratories
$129
Boehringer Ingelheim Pharmaceuticals, Inc.
$105
ABBVIE INC.
$93
Horizon Therapeutics plc
$84
Shire North American Group Inc
$82
Radius Health, Inc.
$81
AstraZeneca Pharmaceuticals LP
$65
Antares Pharma, Inc.
$56
Mannkind Corporation
$48
AbbVie, Inc.
$45
Ascendis Pharma Inc
$29
AbbVie Inc.
$27
DEXCOM, INC.
$25
MannKind Corporation
$23
Xeris Pharmaceuticals, Inc.
$23
IBSA Pharma Inc.
$22
Dexcom, Inc.
$21
PFIZER INC.
$19
Zealand Pharma US, Inc.
$18
Azurity Pharmaceuticals, Inc.
$15
ARBOR PHARMACEUTICALS, INC.
$15
Top 3 companies account for 49.3% of all-time payments
Associated products mentioned in payments ›
AFREZZA · Adthyza · BAQSIMI · Corlanor · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · EMGALITY · EVENITY · Edarbi · FARXIGA · FORTEO · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · GVOKE HYPOPEN · HUMALOG · HUMULIN · JANUVIA · JARDIANCE · LINZESS · MOUNJARO · NATPARA · NATPARA (PARATHYROID HORMONE) · Ozempic · PAXLOVID · Prolia · RYBELSUS · Repatha · Rybelsus · SOLIQUA 100/33 · SYNTHROID · Saxenda · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tresiba · Tymlos · UBRELVY · Wegovy · XYOSTED · ZEGALOGUE
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an endocrinology specialist in Los Angeles?
Compare endocrinologists in the Los Angeles area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
260
Per 100K population
2.6
County median income
$87,760
Nearest hospital
VA GREATER LOS ANGELES HEALTHCARE SYSTEM
1.1 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Geola is a clinical cardiology specialist, with above-average Medicare volume (top 29% in CA), with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Geola experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Geola performed 777 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Geola receive payments from pharmaceutical companies?
Yes. Dr. Geola received a total of $2,891 from 26 companies across 123 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Geola's costs compare to other endocrinologists in Los Angeles?
Dr. Geola's average Medicare payment per service is $91. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Geola) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →